Symptom profiles and inflammatory markers in moderate to severe COPD. - Wikidata - awgldk - TriplyDB

Symptom profiles and inflammatory markers in moderate to severe COPD.

Symptom profiles and inflammatory markers in moderate to severe COPD.

http://www.wikidata.org/entity/Q37470410

about

Effects of Glutathione S-Transferase Gene Polymorphisms and Antioxidant Capacity per Unit Albumin on the Pathogenesis of Chronic Obstructive Pulmonary Disease

P2860

Q41689958-810A6AFA-4146-4774-ABC2-015D8B91A922

P2860

Symptom profiles and inflammatory markers in moderate to severe COPD.

http://www.wikidata.org/entity/Q37470410

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 03 December 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Symptom profiles and inflammatory markers in moderate to severe COPD.

@en

Symptom profiles and inflammatory markers in moderate to severe COPD.

@nl

type

label

Symptom profiles and inflammatory markers in moderate to severe COPD.

@en

Symptom profiles and inflammatory markers in moderate to severe COPD.

@nl

prefLabel

Symptom profiles and inflammatory markers in moderate to severe COPD.

@en

Symptom profiles and inflammatory markers in moderate to severe COPD.

@nl

P1433

Q37470410-21F2ACCA-24D5-483E-98D2-88ED5B1B08B5

P1476

Q37470410-2A45A476-0AA8-4C8C-B540-A2A76FA54994

P2093

Q37470410-1C3A6B47-8EFE-40A6-B643-A7F42C3E577A

Q37470410-46C5CF8F-86D4-41E1-ACB0-58D28A1158A5

Q37470410-6102EE2B-4DDE-4445-8064-0E34FC88AC84

Q37470410-90EE5C3D-D078-4171-8D99-C28F19A6DE73

Q37470410-AB9863DC-444E-4049-B88A-A8515AF79FC7

Q37470410-BDE42D9A-7226-4D2B-9937-50DE77EDCED7

Q37470410-D9DE4620-045D-4943-BF38-0CD3F312D729

Q37470410-E9099B5B-5EFE-402E-9FC2-C899281A6BF3

P2860

Q37470410-26717CE4-6FD2-4FE6-A485-286FF828FB58

Q37470410-2C5160DC-3CDB-4DED-9468-66209038538A

Q37470410-2F85C238-EE07-4D9C-BB04-4F015747B9DE

Q37470410-31128959-C6F7-4B95-BE15-DA5F91C5220B

Q37470410-397931E2-9EFE-48D7-92EA-FEDFF756BBCD

Q37470410-3EBCD702-9270-4937-8178-2FEA2CDD67E6

Q37470410-56B7F2B3-59C2-4B2B-8D10-DC34C0D510E8

Q37470410-63FAEECE-9B95-4D86-83E6-78605B62BA9B

Q37470410-6FBEB775-F061-4C14-A1B7-99F920977593

Q37470410-7DEABEB8-256B-44ED-8882-64258C0F95D9

P2888

Q37470410-ED9637FB-2ADC-4464-A8B4-4B72F2FDA396

P304

Q37470410-513050E2-7E42-46CC-826D-202B97A2BB19

P31

Q37470410-BAB77861-1E39-470D-8EA2-1D1B39A74FEF

P356

Q37470410-9169DA7A-6230-44EC-ADD5-F830472DC691

P433

Q37470410-9152A41E-2F1F-4E86-A422-754926183CBD

P478

Q37470410-D72AD842-BEF0-43C0-8D09-225FC8BF283D

P50

Q37470410-E9A27F09-911D-44F9-8510-5E02B2A24315

P577

Q37470410-7C067068-0E87-4187-A4E6-4965BD849700

P6179

Q37470410-403B10EF-65EA-4657-8AC8-51652B86E956

P698

Q37470410-1FF6C449-1690-423A-BAA6-3943092213F8

P921

Q37470410-DBC482D6-F9CC-4BEF-A95C-09762FB30280

P932

Q37470410-2AD7CBCB-D53B-470C-A73B-08866A124D3B

P356

S12890-016-0330-1

P1433

BMC Pulmonary Medicine

P1476

Symptom profiles and inflammatory markers in moderate to severe COPD.

@en

P2093

Gustavo Matute-Bello

http://www.w3.org/2001/XMLSchema#string

Huong Q Nguyen

http://www.w3.org/2001/XMLSchema#string

Jerald R Herting

http://www.w3.org/2001/XMLSchema#string

Kenneth C Pike

http://www.w3.org/2001/XMLSchema#string

Ruth Kohen

http://www.w3.org/2001/XMLSchema#string

Sandra G Adams

http://www.w3.org/2001/XMLSchema#string

Soo Borson

http://www.w3.org/2001/XMLSchema#string

Vincent S Fan

http://www.w3.org/2001/XMLSchema#string

P2860

From inflammation to sickness and depression: when the immune system subjugates the brain

The MOS 36-ltem Short-Form Health Survey (SF-36)

Subgroup analysis of symptoms and their effect on functioning, exercise capacity, and physical activity in patients with severe chronic obstructive pulmonary disease.

An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea.

Symptom cluster, healthcare use and mortality in patients with severe chronic obstructive pulmonary disease.

Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence.

Altered gene expression in blood and sputum in COPD frequent exacerbators in the ECLIPSE cohort.

Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype

Dyspnea and pain frequently co-occur among Medicare managed care recipients.

Biomarkers of systemic inflammation and depression and fatigue in moderate clinically stable COPD

P2888

s12890-016-0330-1

P304

173

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12890-016-0330-1

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-12-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1049195015

http://www.w3.org/2001/XMLSchema#string

P698

27914470

http://www.w3.org/2001/XMLSchema#string

P921

chronic obstructive pulmonary disease

P932

5135800

http://www.w3.org/2001/XMLSchema#string